Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 8.372\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a.) CCOC(=O)N1CCN(C(=O)COc2ccccc2Cl)CC1
b.) CN(C(=O)c1ccco1)c1ccccc1C(=O)O
c.) CCC(=S)/C=C1\Sc2ccccc2N1CCCS(=O)(=O)[O-].[Na+]
d.) O=C(COC(=O)c1ccc2ccccc2c1O)NCc1ccccc1
Answer: c. CCC(=S)/C=C1\Sc2ccccc2N1CCCS(=O)(=O)[O-].[Na+]
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=S)/C=C1\Sc2ccccc2N1CCCS(=O)(=O)[O-].[Na+]
CCC(=S)/C=C1\Sc2ccccc2N1CCCS(=O)(=O)[O-].[Na+]
sodium;3-[(2Z)-2-(2-sulfanylidenebutylidene)-1,3-benzothiazol-3-yl]propane-1-sulfonate